Apoptosis induced by methylene-blue-mediated photodynamic therapy in melanomas and the involvement of mitochondrial dysfunction revealed by proteomics

Cancer Science

Volumn 99, Issue 10, 2008, Pages 2019-2027

  Chen, Yongjun ^a   Zheng, Wei ^a   Li, Yingqian ^a   Zhong, Jieying ^a   Ji, Jianguo ^b   Shen, Pingping ^a  

^a NANJING UNIVERSITY   (China)

^b PEKING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 9; CASPASE INHIBITOR; GLUTATHIONE; METHYLENE BLUE; MITOCHONDRIAL PROTEIN; PHOTOSENSITIZING AGENT; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; CELL DEATH; CELL VIABILITY; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ELECTRON TRANSPORT; ENZYME ACTIVATION; ENZYME INHIBITION; IN VITRO STUDY; IN VIVO STUDY; MELANOMA; MELANOMA CELL; MOUSE; NONHUMAN; OXIDATIVE STRESS; PHOTOCHEMISTRY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEOMICS; SURVIVAL TIME; TUMOR VOLUME;

ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; IMMUNOHISTOCHEMISTRY; MELANOMA, EXPERIMENTAL; MEMBRANE POTENTIAL, MITOCHONDRIAL; METHYLENE BLUE; MICE; MITOCHONDRIA; MODELS, BIOLOGICAL; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PROTEOMICS;

EID: 54949156442     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2008.00910.x     Document Type: Article

References (36)

1. Dougherty TJ, Gomer CJ, Henderson BW et al. Photodynamic therapy. J Natl Cancer Inst 1998; 90: 889-905.
2. Almeida RD, Manadas BJ, Carvalho AP et al. Intracellular signaling mechanisms in photodynamic therapy. Biochim Biophys Acta 2004; 1704: 59-86.
3. Hopper C. Photodynamic therapy: A clinical reality in the treatment of cancer. Lancet Oncol 2000; 1: 212-19.
4. Dolmans DE, Fukumura D, Jain RK. Photodynamic therapy for cancer. Nat Rev Cancer 2003; 3: 380-7.
5. Chudnovsky Y, Khavari PA, Adams AE. Melanoma genetics and the development of rational therapeutics. J Clin Invest 2005; 115: 813-24.
6. Gray-Schopfer V, Wellbrock C, Marais R. Melanoma biology and new targeted therapy. Nature 2007; 445: 851-7.
7. Soengas MS, Lowe SW. Apoptosis and melanoma chemoresistance. Oncogene 2003; 22: 3138-51.
8. Woodburn KW, Fan Q, Kessel D et al. Photodynamic therapy of B16F10 murine melanoma with lutetium texaphyrin. J Invest Dermatol 1998; 110: 746-51.
9. Sheleg SV, Zhavrid EA, Khodina TV et al. Photodynamic therapy with chlorin e(6) for skin metastases of melanoma. Photodermatol Photoimmunol Photomed 2004; 20: 21-6.
10. Córdoba F, Braathen LR, Weissenberger J et al. 5-aminolaevulinic acid photodynamic therapy in a transgenic mouse model of skin melanoma. Exp Dermatol 2005; 14: 429-37.
11. Gabrielli D, Belisle E, Severino D et al. Binding, aggregation and photochemical properties of methylene blue in mitochondrial suspensions. Photochem Photobiol 2004; 79: 227-32.
12. Tardivo JP, Giglio AD, Oliveira C et al. Methylene blue in photodynamic therapy: From basic mechanisms to clinical applications. Photodiagnosis Photodynamic Ther 2005; 2: 175-91.
13. 211At-methylene blue for pigmented melanoma in an animal model system. Cancer Res 1989; 49: 4332-7.
14. Noodt BB, Rodal GH, Wainwright M et al. Apoptosis induction by different pathways with methylene blue derivative and light from mitochondrial sites in V79 cells. Int J Cancer 1998; 75: 941-8.
15. Ball DJ, Luo Y, Kessel D et al. The induction of apoptosis by a positively charged methylene blue derivative. J Photochem Photobiol B 1998; 42: 159-63.
16. Tardivo JP, Giglio AD, Paschoal LHC et al. Treatment of melanoma lesions using methylene blue and RL50 light source. Photodiagnosis Photodynamic Ther 2004; 1: 345-6.
17. Tong Z, Singh G, Rainbow AJ. Sustained activation of the extracellular signal-regulated kinase pathway protects cells from photofrin-mediated photodynamic therapy. Cancer Res 2002; 62: 5528-35.
18. Zhou B, Yang W, Ji JG et al. Differential display proteome analysis of PC-12 cells transiently transfected with metallothionein-3 gene. J Proteome Res 2004; 3: 126-31.
19. Strasser A, O'Connor L, Dixit VM. Apoptosis signaling. Annu Rev Biochem 2000; 69: 217-45.
20. Waterhouse NJ, Goldstein JC, Ahsen OV et al. Cytochrome C maintains mitochondrial transmembrane potential and ATP generation after outer mitochondrial membrane permeabilization during the apoptotic process. J Cell Biol 2001; 153: 319-28.
21. Magi B, Ettorre A, Liberatori S et al. Selectivity of protein carbonylation in the apoptotic response to oxidative stress associated with photodynamic therapy: A cell biochemical and proteomic investigation. Cell Death Differ 2004; 11: 842-52.
22. Lee C, Kim HJ, Lee YR et al. Analysis of peroxiredoxin decreasing oxidative stress in hypertensive aortic smooth muscle. Biochim Biophys Acta 2007; 1774: 848-55.
23. Houmard JA, Weidner ML, Gavigan KE et al. Fiber type and citrate synthase activity in the human gastrocnemius and vastus lateralis with aging. J Appl Physiol 1998; 85: 1337-41.
24. Zickermann V, Bostina M, Hunte C et al. Functional implications from an unexpected position of the 49-kDa subunit of NADH:uBiquinone oxidoreductase. J Biol Chem 2003; 278: 29072-8.
25. Johnson A, Gin P, Marbois BN et al. COQ9, a new gene required for the biosynthesis of coenzyme Q in saccharomyces cerevisiae. J Biol Chem 2005; 280: 31397-404.
26. Degterev A, Boyce M, Yuan J. A decade of caspases. Oncogene 2003; 22: 8543-67.
27. Galkin A, Brandt U. Superoxide radical formation by pure complex I (NADH:uBiquinone oxidoreductase) from Yarrowia lipolytica. J Biol Chem 2005; 280: 30129-35.
28. Kussmaul L, Hirst J. The mechanism of superoxide production by NADH:uBiquinone oxidoreductase (complex I) from bovine heart mitochondria. Proc Natl Acad Sci USA 2006; 103: 7607-12.
29. Galluzzi L, Larochette N, Zamzami N et al. Mitochondria as therapeutic targets for cancer chemotherapy. Oncogene 2006; 25: 4812-30.
30. Short KR, Bigelow ML, Kahl J et al. Decline in skeletal muscle mitochondrial function with aging in humans. Proc Natl Acad Sci USA 2005; 102: 5618-23.
31. Ben-Ze'ev A, Raz A. Relationship between the organization and synthesis of vimentin and the metastatic capability of B16 melanoma cells. Cancer Res 1985; 45: 2632-41.
32. Lee E, Nichols P, Spicer D et al. GRP78 as a novel predictor of responsiveness to chemotherapy in breast cancer. Cancer Res 2006; 66: 7849-53.
33. Jean S, Bideau C, Bellon L et al. The expression of genes induced in melanocytes by exposure to 365-nm UVA: Study by cDNA arrays and real-time quantitative RT-PCR. Biochim Biophys Acta 2001; 1522: 89-96.
34. Hua GQ, Zhang QX, Fan ZS. Heat shock protein 75 (TRAP1) antagonizes reactive oxygen species generation and protects cells from granzyme M-mediated apoptosis. J Biol Chem 2007; 282: 20553-60.
35. Hu Z, Tong C. Synchronous fluorescence determination of DNA based on the interaction between methylene blue and DNA. Anal Chim Acta 2007; 587: 187-93.
36. Orth K, Beck G, Genze F et al. Methylene blue mediated photodynamic therapy in experimental colorectal tumors in mice. J Photochem Photobiol B 2000; 57: 186-92.